7/18/2025Recent Executive Moves

7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410

7/18/2025China Releases 2nd Batch of Clinical Guidelines for Rare Diseases, Cov...

7/18/2025China Seeks Comments on 96th Batch of Reference Formulations for Gener...

7/18/2025China Unveils New Clinical Trial Guidelines for Antibacterial Drugs Ta...

7/18/2025China Issues New Draft Guidelines for Pharmaceutical Development of Or...

7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...

7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...

7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...

7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...

7/18/2025Novartis CEO Highlights China Momentum in Q2 2025 Earnings Call

More>>

7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...

7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)

7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...

6/27/2025Analyzing Key Trends in China's Patent-Linkage System and Their Impact...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...

More>>